Hepatic metastasectomy as a cytoreductive strategy for the treatment of liver metastases in breast cancer: review of literature.
The resection of liver metastases in breast cancer patients is a controversial therapeutical approach. No data of prospective randomized trials are available, thus evidence for the potential role of hepatic metastasectomy rests on retrospective studies with a small number of patients. Techniqual advances however have rendered hepatic metastasectomy safe and the long-term results of some studies possibly support the role of a surgical approach in selected patients.